# Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

> **NCT00657514** · PHASE4 · WITHDRAWN · sponsor: **Colorado Prevention Center**

## Conditions studied

- Peripheral Arterial Disease
- Angina

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00657514
- **Lead sponsor:** Colorado Prevention Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient enrollment
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657514, "Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00657514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*